EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Non-Islet Cell Tumor Hypoglycemia in Metastatic Breast Adenocarcinoma: Resolution Following Transition to Elacestrant Therapy

Payton Schultz, Aimen Iqbal, Susanne Trost

AACE Endocrinology and Diabetes · 2026-09

DOI: 10.1016/j.aed.2026.09.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-09. Verfasst von Payton Schultz und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Schultz, P., Iqbal, A., & Trost, S. (2026). Non-Islet Cell Tumor Hypoglycemia in Metastatic Breast Adenocarcinoma: Resolution Following Transition to Elacestrant Therapy. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.09.008

Vancouver

Schultz P, Iqbal A, Trost S. Non-Islet Cell Tumor Hypoglycemia in Metastatic Breast Adenocarcinoma: Resolution Following Transition to Elacestrant Therapy. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.09.008

BibTeX
@article{Schultz2026,
  author = {Schultz, Payton and Iqbal, Aimen and Trost, Susanne},
  title = {Non-Islet Cell Tumor Hypoglycemia in Metastatic Breast Adenocarcinoma: Resolution Following Transition to Elacestrant Therapy},
  journal = {AACE Endocrinology and Diabetes},
  year = {2026},
  doi = {10.1016/j.aed.2026.09.008}
}
Kostenlos starten →